SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C.

                                    FORM 10-Q
                                 Amendment No. 1

             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934.

                 For the Quarterly Period Ended January 3, 2004

                                       OR

             TRANSITIONAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

              For the Transition Period From _________ to ________.

                         Commission File Number 0-11392

                       SPAN-AMERICA MEDICAL SYSTEMS, INC.
             (Exact name of Registrant as specified in its charter)

                  South Carolina                  57-0525804
                  --------------                  ----------
           (State or other jurisdiction        (I.R.S. Employer
                       of                     Identification Number)
            incorporation or organization)

                               70 Commerce Center
                        Greenville, South Carolina 29615
               (Address of Principal Executive Offices) (Zip Code)

       Registrant's telephone number, including area code: (864) 288-8877

                                 Not Applicable
               Former name, former address and former fiscal year,
                         if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter periods that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes |X| No |_|


Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12b-2of the Exchange Act). Yes |_| No |X|

                      APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer's class of
common stock, as of the latest practical date.

           Common Stock, No Par Value - 2,572,218 shares as of 1/30/04

Explanatory Note: This Amendment is filed to add the statement above related to
accelerated filer status.







                                  EXHIBIT INDEX


Exhibit Description
No.

31.1    Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2    Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32      Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002









                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                SPAN-AMERICA MEDICAL SYSTEMS, INC.


                                /s/ Richard C. Coggins
                                    ----------------------------------
                                Richard C. Coggins
                                Chief Financial Officer


                                /s/ James D. Ferguson
                                    ----------------------------------
                                James D. Ferguson
                                President and Chief Executive Officer



DATE:     May 11, 2004